AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Imerys

AGM Information May 3, 2017

1431_iss_2017-05-03_14d0c71e-4312-48ca-a798-c6dbe4bcd1ca.pdf

AGM Information

Open in Viewer

Opens in native device viewer

Ordinary & Extraordinary Shareholders' General Meeting of May 3, 2017

Imerys Shareholders' General Meeting held today in Paris and chaired by Mr. Gilles Michel, Chairman and Chief Executive Officer, approved all the resolutions presented by the Board of Directors.

APPROVAL OF 2016 FINANCIAL STATEMENTS

In particular, the shareholders approved the statutory and consolidated financial statements for 2016, which report a net income from current operations, Group share, of €362.1 million, up + 6.0% compared with 2015.

DIVIDEND

The Shareholders' General Meeting decided to distribute a €1.87 dividend per share, representing a + 6.9% increase from financial 2015. This dividend will be paid out as from May 11, 2017.

GOVERNANCE

The Shareholders' General Meeting also approved:

  • the renewal of the terms of office as Directors of Mrs. Marion Guillou and Messrs. Aldo Cardoso, Paul Desmarais III and Colin Hall, for a 3-year period;
  • the appointment of Mrs. Martina Merz as a new Director for a 3-year period, contributing to the increase in the diversity of directors' profiles.

Mrs. Arielle Malard de Rothschild's who did not solicit the renewal of her term of office which expires was warmly thanked for her contribution to the works of the Board and of its Committees she was a member of.

Following the Shareholders' General Meeting, the Board of Directors is comprised of 17 members including 2 employee representative directors, 6 independent members and 6 women, the proportion of which represents 40% in the Board composition (excluding the employee representative directors).

Voting results per resolution, as well as the presentation of the Shareholders' General Meeting are available on the Group's website www.imerys.com.

Financial agenda 2017

July 27 (before market st half 2017 results
opening) 1
October 31 (after market rd quarter 2017 results
close) 3

These dates are tentative and may be updated on the Group's website at www.imerys.com, in the Investors & Analysts / Financial Agenda section.

_______________________________________________________________________________________________________________________________________

The world leader in mineral-based specialty solutions for industry, with €4.2 billion revenue and close to 16,000 employees, Imerys delivers high value-added, functional solutions to a great number of sectors, from processing industries to consumer goods. The Group draws on its knowledge of applications, technological expertise and its material science know-how to deliver resources based on beneficiation of its mineral resources, synthetic minerals and formulations. These contribute essential properties to customers' products and performance, including refractoriness, hardness, conductivity, opacity, durability, purity, lightness, filtration, absorption and repellency. Imerys is determined to develop responsibly, in particular by fostering the emergence of environmentally-friendly products and processes.

More comprehensive information about Imerys may be obtained from its website (www.imerys.com) under Regulated Information, particularly in its Registration Document filed with Autorité des marchés financiers on March 21, 2017 under number D.17-0190 (also available from the Autorité des marchés financiers website, www.amf-france.org). Imerys draws the attention of investors to chapter 4, "Risk Factors and Internal Control", of its Registration Document.

_______________________________________________________________________________________________________________________________________

Disclaimer: This document contains projections and other forward-looking statements. Investors are cautioned that such projections and forward-looking statements are subject to various risks and uncertainties (many of which are difficult to predict and generally beyond the control of Imerys) that could cause actual results and developments to differ materially from those expressed or implied.

Analyst / Investor Relations: Press contacts:
Vincent Gouley - +33 (0)1 4955 6469 Vincent Gouley - +33 (0)1 4955 6469
[email protected] Philémon Tassel - +33 (0)6 3010 9611
Sarah Fornier - +33 (0)7 8740 8350

Talk to a Data Expert

Have a question? We'll get back to you promptly.